Date | Time | Source | Headline | Symbol | Company |
03/05/2014 | 4:02PM | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
03/05/2014 | 6:06AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
03/05/2014 | 6:06AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
03/04/2014 | 10:00AM | GlobeNewswire Inc. | Sucampo and National Cherry Blossom Festival Announce Sucampo as Host and 'Step Into Spring' Program Sponsor for 2014 | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/26/2014 | 4:02PM | GlobeNewswire Inc. | Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/21/2014 | 3:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/19/2014 | 11:29AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/14/2014 | 8:18AM | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2014 | 4:11PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/12/2014 | 2:31PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/12/2014 | 2:28PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/12/2014 | 2:09PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/12/2014 | 2:08PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/12/2014 | 2:06PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/12/2014 | 6:45AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/12/2014 | 6:45AM | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Fourth Quarter and Full Year 2013 Results and Operating Highlights Teleconference and Webca... | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/10/2014 | 4:02PM | GlobeNewswire Inc. | Sucampo Names Peter Greenleaf Chief Executive Officer | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/06/2014 | 6:45AM | GlobeNewswire Inc. | All Physicians in Switzerland Are Now Able to Prescribe Sucampo's AMITIZA(R) for Chronic Idiopathic Constipation | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/05/2014 | 6:45AM | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 Leerink Global Healthcare Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
12/26/2013 | 5:00PM | Zacks | Sucampo Reports Data - Analyst Blog | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
12/23/2013 | 6:45AM | GlobeNewswire Inc. | Sucampo Reports Results from Phase 2a Study of Intravenous Ion Channel Activator for Lumbar Spinal Stenosis | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
12/17/2013 | 6:45AM | GlobeNewswire Inc. | Sucampo and Takeda Initiate Global Pivotal Phase 3 Program of Lubiprostone in Pediatric Functional Constipation | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
12/04/2013 | 8:57AM | Zacks | Galectin Therapeutics (GALT) in Focus: Stock Moves Up 13.2% - Tale of the Tape | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
11/19/2013 | 12:33PM | Zacks | Prescription for Profit - Zacks Industry Rank Analysis | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
11/19/2013 | 12:33PM | Zacks | Prescription for Profit - Zacks Industry Rank Analysis | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
11/13/2013 | 6:46AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
11/08/2013 | 11:35AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
11/06/2013 | 6:45AM | GlobeNewswire Inc. | Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2013 Credit Suisse Healthcare Conference | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
11/05/2013 | 4:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
11/05/2013 | 4:02PM | GlobeNewswire Inc. | Sucampo Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2013 Financial and Operating Results | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |